The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

FDA warns Eye­Point over eye im­plant man­u­fac­tur­ing woes

9 months ago
FDA+

No­var­tis part­ners with small North Car­oli­na biotech to make its bi­o­log­ics more 'con­ve­nien­t'

9 months ago
Startups
Deals

Eli Lil­ly re­leas­es sin­gle-dose vials of Zep­bound at half the price of oth­er obe­si­ty meds

9 months ago
Pharma

As­traZeneca pours $135M in­to boost­ing bi­o­log­ics ca­pac­i­ty in Swe­den 

9 months ago
Pharma

CDER chief says 's­tan­dards have not changed,' ex­plain­ing in­crease in CRLs for bi­o­log­ics

9 months ago
FDA+

Fu­ji­film Diosynth opens new UK fa­cil­i­ty; Bo­ra com­pletes Emer­gent fac­to­ry buy

9 months ago

WuXi Bio spot­lights new US con­tracts, but prof­its are down as Biose­cure brews

9 months ago
China

In­di­an CD­MOs un­like­ly to see sud­den surge in clients if Chi­na bill pass­es, ex­ecs say 

9 months ago
China

FDA re­jects Re­gen­eron’s mul­ti­ple myelo­ma bis­pe­cif­ic an­ti­body over man­u­fac­tur­ing is­sues

9 months ago
R&D

WuXi Bi­o­log­ics’ ADC spin­out re­ports rev­enue jump de­spite Biose­cure risk

9 months ago
China

Emer­gent joins broad­er ef­forts for mpox vac­cine dri­ve in Africa

9 months ago
Pharma

No­vo Nordisk sub­sidiary to build $220M API fa­cil­i­ty for chron­ic dis­ease drugs

9 months ago

Bavar­i­an Nordic re­turns to the spot­light as mpox out­break reach­es emer­gency state

9 months ago
Pharma

Mer­ck signs MoU with In­di­an CD­MO; Scor­pius de­lays pub­lic of­fer­ing

9 months ago

Evotec to cut 400 work­ers and close sites, cit­ing ‘no new sig­nals of re­cov­ery’ this year

9 months ago
Pharma

Ex­clu­sive: Gates Foun­da­tion backs start­up us­ing op­to­ge­net­ics to man­u­fac­ture bi­o­log­ics

9 months ago
Financing
R&D

Pres­sure from an­ti-Chi­na leg­is­la­tion be­gins to rip­ple through bio­phar­ma

9 months ago
China
Pharma

Leg­end con­tin­ues Carvyk­ti fac­to­ry builds to ce­ment CAR-T ter­ri­to­ry with J&J

9 months ago
Pharma
Cell/Gene Tx

Cor­rect­ed: No­vo Nordisk to file in EU and Chi­na with late-phase in­sulin plus semaglu­tide da­ta – but not yet in the US

9 months ago
R&D
FDA+

No­vavax plots to re­duce Eu­ro­pean foot­print to be­come a ‘lean­er’ com­pa­ny

9 months ago
Pharma

Lil­ly con­tributes to iso­tope sup­pli­er fundraise; Lay­offs at Aji­nomo­to   

9 months ago

WuXi Bio gains some trac­tion in Eu­rope in the face of Biose­cure threat in the US

9 months ago
China

Lil­ly crush­es ex­pec­ta­tions with GLP-1 fran­chise, as sup­ply con­straints ease

9 months ago
Pharma

Big drug­mak­ers have cut out­side R&D spend­ing amid broad pull­back, key con­trac­tor warns

9 months ago
Pharma
First page Previous page 891011121314 Next page Last page
A service from the Financial Times